Murray D. Norris

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

61h-index13.5kcitations513works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(289), Acute Lymphoblastic Leukemia research(81), Cancer, Hypoxia, and Metabolism(65), Cancer therapeutics and mechanisms(60), Protein Degradation and Inhibitors(59)

Publications512 total

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma
Science Advances·2025Open Access
P-glycoprotein as a chemotherapy resistance mechanism and biomarker of poor response in high-risk neuroblastoma
EJC Paediatric Oncology·2025· 1 citedOpen Access
Abstract B079: The glycogen synthase kinase-3β inhibitor 9-ING-41 in combination with chemoimmunotherapy provides long-term survival in the Th-MYCN mouse model
Molecular Cancer Therapeutics·2025
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma
Journal of Experimental & Clinical Cancer Research·2025Open Access
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response
Proceedings of the National Academy of Sciences·2025· 3 citedOpen Access
EPS6.04Abridging the 22-item Sino-Nasal Outcome Test (SNOT-22) in people with cystic fibrosis to limit survey burden
Journal of Cystic Fibrosis·2025
Inclusion of JNK-independent drugs within multi-agent chemotherapy improves response in relapsed high-risk neuroblastoma
2025Open Access
Polyamine depletion limits progression of acute leukaemia
International Journal of Cancer·2025· 6 citedOpen Access
The polyamine transporter <scp>ATP13A3</scp> mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma
Molecular Oncology·2025· 7 citedOpen Access
Spatial profiling of endoplasmic reticulum stress markers in tumor associated cells predicts patient outcomes in pancreatic cancer
Neoplasia·2025· 4 citedOpen Access
Combined inhibition of histone methyltransferases <scp>EZH2</scp> and <scp>DOT1L</scp> is an effective therapy for neuroblastoma
Cancer Medicine·2024· 5 citedOpen Access
Author response for "The polyamine transporter &lt;scp&gt;ATP13A3&lt;/scp&gt; mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma"
2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis
Communications Biology·2024· 1 citedOpen Access
24 (PB012): Runx1t1 is an epigenetic regulator essential for MYCN-driven neuroblastoma tumorigenesis
European Journal of Cancer·2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
Nature Communications·2024· 9 citedOpen Access
Author response for "The polyamine transporter &lt;scp&gt;ATP13A3&lt;/scp&gt; mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma"
2024
P059 Associations between olfactory dysfunction, eating-related quality of life, chronic rhinosinusitis, and highly effective modulator therapy in people with cystic fibrosis
Journal of Cystic Fibrosis·2024· 1 cited
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML
Blood·2024· 19 citedOpen Access
The polyamine transporter ATP13A3 mediates DFMO-induced polyamine uptake in neuroblastoma
2024· 4 citedOpen Access
FDA-approved disulfiram as a novel treatment for aggressive leukemia
Journal of Molecular Medicine·2024· 13 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

Michelle Haber(49), Glenn M. Marshall(28), Tao Liu(12), Claudia L. Flemming(10), Michelle J. Henderson(9), Toby N. Trahair(9), Belamy B. Cheung(9), Maria Kavallaris(8), Giovanni Perini(8), Jamie I. Fletcher(7), Jayne Murray(7), Wendy B. London(7), David S. Ziegler(6), Susan L. Cohn(6), Janice Madafiglio(6), Catherine A. Burkhart(5), Chelsea Mayoh(5), Andrew J. Gifford(5), Eric Sekyere(5), Janice Smith(5)